tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ZVRA Stock Latest News

Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Press ReleasesZevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
10d ago
ZVRA
Zevra Therapeutics presents new data from arimoclomoal EAP
PremiumThe Fly
Zevra Therapeutics presents new data from arimoclomoal EAP
10d ago
ZVRA
Zevra Therapeutics Bolsters Finance Strategy with $100M Loan
PremiumCompany Announcements
Zevra Therapeutics Bolsters Finance Strategy with $100M Loan
16d ago
8K
ZVRA
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
PremiumPress Releases
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
16d ago
ZVRA
Zevra Therapeutics refinances existing debt with $100M in committed capital
PremiumThe Fly
Zevra Therapeutics refinances existing debt with $100M in committed capital
16d ago
ZVRA
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
PremiumPress ReleasesZevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
29d ago
ZVRA
Zevra Therapeutics reports Q4 EPS (51c), consensus (27c)
PremiumThe Fly
Zevra Therapeutics reports Q4 EPS (51c), consensus (27c)
29d ago
ZVRA
Options Volatility and Implied Earnings Moves Today, March 28, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 28, 2024
29d ago
PL
SOL
Zevra Therapeutics’ KP1077 Shows Promise in Phase 2 Trial
PremiumCompany Announcements
Zevra Therapeutics’ KP1077 Shows Promise in Phase 2 Trial
30d ago
8K
ZVRA
Zevra announces data from the Phase 2 clinical trial of KP1077or SDX for IH
PremiumThe Fly
Zevra announces data from the Phase 2 clinical trial of KP1077or SDX for IH
1M ago
ZVRA
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
PremiumPress Releases
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
1M ago
ZVRA
ZVRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ZVRA Upcoming Earnings Report: What to Expect?
1M ago
ZVRA
Zevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
PremiumPress ReleasesZevra Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
1M ago
ZVRA
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
1M ago
PL
RH
Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
PremiumPress Releases
Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
1M ago
ZVRA
Zevra initiated with Outperform into transformational 2024 at William Blair
PremiumThe Fly
Zevra initiated with Outperform into transformational 2024 at William Blair
1M ago
ZVRA
Zevra Therapeutics initiated with an Outperform at William Blair
PremiumThe Fly
Zevra Therapeutics initiated with an Outperform at William Blair
1M ago
ZVRA
Zevra Therapeutics Releases New Investor Presentation
PremiumCompany Announcements
Zevra Therapeutics Releases New Investor Presentation
2M ago
8K
ZVRA
Zevra Therapeutics Awaits FDA Decision on Arimoclomol
PremiumCompany Announcements
Zevra Therapeutics Awaits FDA Decision on Arimoclomol
2M ago
8K
ZVRA
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
PremiumPress ReleasesZevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
2M ago
ZVRA
Zevra Therapeutics says FDA extends review period for arimoclomol NDA
PremiumThe Fly
Zevra Therapeutics says FDA extends review period for arimoclomol NDA
2M ago
ZVRA
Zevra Therapeutics to Participate at Upcoming Investor Conferences
PremiumPress Releases
Zevra Therapeutics to Participate at Upcoming Investor Conferences
2M ago
ZVRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >